Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.
about
Highlight on advances in nontuberculous mycobacterial disease in North America.Clinical and laboratory aspects of the diagnosis and management of cutaneous and subcutaneous infections caused by rapidly growing mycobacteriaNontuberculous mycobacterial disease mortality in the United States, 1999-2010: a population-based comparative study.Differential diagnostic assays for discriminating mycobacteria, especially for nontuberculous mycobacteria: what does the future hold?Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium.Recent trends in clinically significant nontuberculous Mycobacteria isolates at a Korean general hospital.Current dilemmas in antimicrobial therapy in cystic fibrosis.Nodular bronchiectatic Mycobacterium avium complex pulmonary disease. Natural course on serial computed tomographic scans.Recovery Rates of Non-Tuberculous Mycobacteria from Clinical Specimens Are Increasing in Korean Tertiary-Care Hospitals.Non-tuberculous mycobacteria mimic of MDR-TB infection in Pott's disease.Increasing Burden of Nontuberculous Mycobacteria in KoreaClinical significance of respiratory isolates for Mycobacterium abscessus complex from pediatric patients.Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea.galK-based suicide vector mediated allelic exchange in Mycobacterium abscessus.Non-tuberculous mycobacterial infections at San Francisco General Hospital.Phagocytosis influences the intracellular survival of via the endoplasmic reticulum stress response
P2860
Q27028191-9B50C614-66FB-466D-AAB5-7E73F35E736FQ28278933-3AF0822B-E223-4433-9E34-6A0168019DF7Q35121799-9093CDBB-A41A-4451-B96B-09835B56B93FQ35562770-B8057851-E32E-4541-BE43-A2B23D84F805Q37072978-E809EE74-A7D1-4330-9630-058CC69C9076Q37453482-E3721ACE-35C5-402A-9B9D-EE6061B03B4EQ38042719-4F5FDB2B-38E7-41F0-930D-A006FE0563D9Q38447697-666C4C3F-9430-4549-AD45-E7189EFC37A0Q40152468-B3F84A55-1887-45CC-A0A0-5ED6205CCDDBQ40528867-DBFC1692-FC33-4D13-BB25-525C99E6FD78Q42332741-10F09F25-AFDE-4D37-90D3-D9C18E18001BQ43835585-6024E20F-BB66-4662-A55C-507C2E755BD5Q47593172-9C48EA0D-EA70-47CD-A2BE-4BF07B881093Q47762869-FDE1D711-9BFE-4054-AACA-CE1C832E3407Q51725556-8D47904F-82D0-4DBD-AB15-57BBE12B8A6EQ57064753-F84A967A-A3BE-4630-B7BB-E171F2525026
P2860
Pulmonary nontuberculous mycobacterial disease: new insights into risk factors for susceptibility, epidemiology, and approaches to management in immunocompetent and immunocompromised patients.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@ast
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@en
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@nl
type
label
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@ast
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@en
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@nl
prefLabel
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@ast
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@en
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@nl
P2860
P1476
Pulmonary nontuberculous mycob ...... nd immunocompromised patients.
@en
P2093
Kenneth N Olivier
Paul Saleeb
P2860
P304
P356
10.1007/S11908-010-0103-6
P577
2010-05-01T00:00:00Z